Study Design, Data Reporting, and Regulatory-Compliant Deliverables

The contract requires the development of a final study design and comprehensive data analysis plans to ensure full regulatory compliance with FDA standards. All deliverables must be submitted in electronic format that meets FDA requirements, including raw data, statistical analyses, study reports, and supporting documentation that adheres to Section 508 accessibility guidelines. The work encompasses end-to-end preparation of scientific and regulatory materials necessary for submission and review, with emphasis on data integrity, reproducibility, and accessibility. This subcontract is issued under the NAICS code 541611 for scientific research and development services by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The opportunity was posted on June 22, 2026, with a response deadline of July 6, 2026, at 5:00 PM. The place of performance and point of contact details are not specified, and there is no set-aside designation indicated. Interested parties must ensure their proposals address all technical and compliance obligations outlined in the scope of work to meet federal regulatory expectations.